Sinofn Health
Sinofn Health
In the contemporary wellness landscape, the role of Dietary Supplements Manufacturers & Factory providers has shifted from simple contract filling to strategic R&D partnerships. As global consumer demand pivots toward personalized nutrition and bio-available formulations, brands require more than just production capacity; they require intellectual capital.
SINOFN Health, backed by the Chinese Academy of Sciences, represents the new standard in nutraceutical manufacturing. By integrating medical research with large-scale production, we provide an "information gain" for our clients—offering deeper insights into formulation stability, bioavailability, and market-ready innovation.
Modern procurement in the dietary supplement industry is undergoing a structural transformation. Enterprises are moving away from fragmented supply chains, instead seeking integrated CDMO (Contract Development and Manufacturing Organization) partners. The primary drivers include:
At the core of our operations is the Tianjin R&D Center, where we bridge the gap between academic innovation and commercial scalability. Led by Dr. Zhang Ying and Dr. Tan Shengjie, our team specializes in:
We leverage advanced delivery systems, including controlled-release matrices, lipid-based nutrient delivery, and encapsulated botanical extracts, ensuring that the active ingredients survive the gastrointestinal tract and deliver the promised benefits.
Understanding regional compliance is the biggest hurdle for global brands. SINOFN provides comprehensive support for:
- ISO 22000 & HACCP Certification for global safety standards.
- Full-Plant Integration: From raw material sourcing to blockchain-verified batch tracking, we ensure total transparency.
“We measure success not just in revenue, but in lives improved through accessible science.” – This philosophy drives our entire R&D pipeline. By focusing on specialized medical foods (FSMP) and functional nutrition, we set a high bar for quality that translates across all our commercial supplement lines. Our commitment to the Phenylketonuria (PKU) community serves as the ethical foundation for everything we manufacture.
We operate GMP-certified facilities with over 10 dedicated production lines for softgels, gummies, powders, and liquids. Our capacity exceeds 500M units annually, supported by automated, high-speed bottling and packaging technologies.
Absolutely. We provide pilot-scale prototyping. Our R&D center, staffed by experts from the Chinese Academy of Sciences and international specialists, conducts bioavailability and stability testing to ensure your formulation is market-ready before full-scale production.
We maintain ISO 22000, HACCP, and FSSC 22000 certifications. Every batch undergoes rigorous HPLC/GC-MS contaminant screening, microbiological safety testing, and real-time stability monitoring to ensure compliance with the target market's specific regulatory requirements.
